US company to offer unapproved anti-ageing gene therapy at overseas clinics

Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma

Life Biosciences, a Boston-based biotech startup, has conducted the world's first gene therapy on a living patient aimed at reversing cellul

The US is hooked on unregulated peptides. But are they effective, or even safe?

AAV-mediated FGF21 gene therapy extends health span and lifespan in aged mice through multi-tissue adaptations

This study demonstrates that a one-time muscle-directed AAV-mediated FGF21 gene therapy in aged and geriatric mice extends health span and l

Method to reverse cellular ageing is about to be tested in humans

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

U.S. restrictions on Chinese biotech could harm patients, argues editorial

The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec

FDA Approves First Dual-AAV Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program

The FDA has approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy for trea